Your browser doesn't support javascript.
loading
Levetiracetam treatment ameliorates LRRK2 pathological mutant phenotype.
Rassu, Mauro; Biosa, Alice; Galioto, Manuela; Fais, Milena; Sini, Paola; Greggio, Elisa; Piccoli, Giovanni; Crosio, Claudia; Iaccarino, Ciro.
Affiliation
  • Rassu M; Department of Biomedical Sciences, University of Sassari, Sassari, Italy.
  • Biosa A; Department of Biology, University of Padova, Padova, Italy.
  • Galioto M; Department of Biomedical Sciences, University of Sassari, Sassari, Italy.
  • Fais M; Department of Biomedical Sciences, University of Sassari, Sassari, Italy.
  • Sini P; Department of Biomedical Sciences, University of Sassari, Sassari, Italy.
  • Greggio E; Department of Biology, University of Padova, Padova, Italy.
  • Piccoli G; Department of Cellular, Computational and Integrative Biology, University of Trento, Trento, Italy.
  • Crosio C; Department of Biomedical Sciences, University of Sassari, Sassari, Italy.
  • Iaccarino C; Department of Biomedical Sciences, University of Sassari, Sassari, Italy.
J Cell Mol Med ; 23(12): 8505-8510, 2019 12.
Article in En | MEDLINE | ID: mdl-31560168

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Synaptic Vesicles / Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 / Levetiracetam / Mutation / Neurons Limits: Animals Language: En Journal: J Cell Mol Med Journal subject: BIOLOGIA MOLECULAR Year: 2019 Document type: Article Affiliation country: Italia Country of publication: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Synaptic Vesicles / Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 / Levetiracetam / Mutation / Neurons Limits: Animals Language: En Journal: J Cell Mol Med Journal subject: BIOLOGIA MOLECULAR Year: 2019 Document type: Article Affiliation country: Italia Country of publication: Reino Unido